Riskpilot← Back to searchSign inGet full accessMEDIPLAST AS
ASActiveOrg 988598348Bjørnstjerne Bjørnsons Gate 110, 3044 DrammenWholesale of pharmaceutical and medical goods · NACE 4646Est. 200510 employeeswww.mediplast.com
Revenue 2024
NOK 144,1M
+20% vs 2023
EBITDA margin
7.6%
-14% vs 2023
Equity ratio
41.5%
Financial strength
Net profit 2024
NOK 8,9M
-13% vs 2023
| Revenue | NOK 144,1M | +20% |
| EBITDA | NOK 11M | -14% |
| Net profit | NOK 8,9M | -13% |
| Total assets | NOK 43,2M | +39% |
| Equity | NOK 17,9M | +5% |
| Employees | 10 | — |
Legal name
MEDIPLAST AS
Org number
988598348
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3. september 2005
Share capital
NOK 1 000 000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Import/eksport, salg av handelsvarer, rådgivning og deltakelse i andre virksomheter.
Address
Bjørnstjerne Bjørnsons Gate 110, 3044 Drammen
Website
www.mediplast.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 187 445 | 117 913 | 111 767 | 120 181 | 144 063 |
| Staff expenses | −7 077 | −8 116 | −9 009 | −9 500 | −10 105 |
| EBITDA | 28 486 | 12 690 | 12 184 | 12 822 | 10 992 |
| Depreciation & amort. | −378 | −368 | −160 | −22 | −55 |
| EBIT | 28 109 | 12 322 | 12 023 | 12 800 | 10 937 |
| Net financials | 162 | −1 | 170 | 383 | 492 |
| Profit before tax | 28 271 | 12 321 | 12 193 | 13 182 | 11 430 |
| Tax | 6 226 | 2 959 | 2 445 | 2 906 | 2 533 |
| Net profit | 22 045 | 9 362 | 9 749 | 10 277 | 8 897 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 43 376 | 34 034 | 34 148 | 31 126 | 43 215 |
| Equity | 9 532 | 18 894 | 15 643 | 17 019 | 17 916 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 33 844 | 15 140 | 18 505 | 14 107 | 25 299 |
| Total debt | 33 844 | 15 140 | 18 505 | 14 107 | 25 299 |
EBITDA margin
7.6%
This company
15.8%
Market median
-52% vs market
20202024
Equity ratio
41.5%
This company
38.2%
Market median
+9% vs market
20202024
Return on equity
49.7%
This company
18.4%
Market median
+170% vs market
20202024
Net profit margin
6.2%
This company
8.1%
Market median
-23% vs market
20202024
Asset turnover
3.33×
This company
1.12×
Market median
+197% vs market
20202024
Debt / equity
1.41×
This company
0.62×
Market median
-127% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JO Chief Executive Officer | Chief Executive Officer | 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Former (2) | ||
| Chairman | 2019 – 2023 | |
| Board of Directors | 2023 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Addlife Development Ab | Company | 100% | 100% | 2024 |
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDIPLAST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Olof Mårten Bongstorp | Chief Executive Officer | 0 companies |
| Rolf Ove Stefan Sandin | Chairman | 0 companies |
| Rolf Ho Bornschein | Board of Directors | 0 companies |
| Anna Christina Rubenhag | Chairman | 0 companies |
| Per Henric Wendel | Board of Directors | 0 companies |